Effect of process parameters on properties of wet-spun poly(L,D-lactide) copolymer multifilament fibers

Poly(L,D-lactide) [P(L,D)LA], LL/D ratio 96/4, and poly(L,DL-lactide) [P(L,DL)LA], L/DL ratio 70/30, multifilament fibers were prepared by wet-spinning and the effects of the spin draw ratio and the coagulant on the morphological, thermal, and mechanical properties of the filaments were studied. The...

Full description

Saved in:
Bibliographic Details
Published in:Journal of applied polymer science Vol. 113; no. 4; pp. 2683 - 2692
Main Authors: Rissanen, Marja, Puolakka, Arja, Hukka, Terttu, Ellä, Ville, Nousiainen, Pertti, Kellomäki, Minna
Format: Journal Article
Language:English
Published: Hoboken Wiley Subscription Services, Inc., A Wiley Company 15-08-2009
Wiley
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Poly(L,D-lactide) [P(L,D)LA], LL/D ratio 96/4, and poly(L,DL-lactide) [P(L,DL)LA], L/DL ratio 70/30, multifilament fibers were prepared by wet-spinning and the effects of the spin draw ratio and the coagulant on the morphological, thermal, and mechanical properties of the filaments were studied. The hydrolytic degradation of filaments was studied in vitro. The filament diameter and the mechanical properties of filaments were highly dependent on the spin draw ratio, whereas the coagulant had no or minor effect. The filament diameters were in the range of 11-36 μm and the maximum tenacity of 150 MPa was obtained at the spin draw ratio of 7.0 for both copolymers. The copolymer had the main importance on the crystallinity of filaments, but it was also affected by the duration of the coagulation process. The crystallinities of P(L,D)LA 96/4 filaments were in the range of 5-16%, whereas P(L,DL)LA 70/30 filaments were totally amorphous. The degree of crystallinity had effect on the hydrolytic degradation of filaments. The tenacity loss of P(L,D)LA 96/4 filaments was about 10% and that of P(L,DL)LA 70/30 filaments was as high as 50% after 24 weeks in vitro.
Bibliography:http://dx.doi.org/10.1002/app.30387
European Commission within the Sixth Framework Programme (2002-2006) - No. NMP-CT-2005-013633 (Biosys: Intelligent Biomaterial Systems for Cardiovascular Tissue Repair)
istex:5D05BB2CC26D71EB83FB8F41E7245C5882AB71C7
ark:/67375/WNG-4292VBQ3-1
ArticleID:APP30387
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:0021-8995
1097-4628
1097-4628
DOI:10.1002/app.30387